Zhuhai, China · Founded 2015 · In IPO Registration
Developer of antibody biopharmaceuticals designed for related medical research services. Trinomab(Zhuhai) is based in Zhuhai, China and was founded in 2015. Its last reported valuation was $534 million in Jun 2025. It has raised $221 million.
Last reported valuation
$533.7M
Oct 2026
Priced at
—
Total raised
$221.2M
Last round
—
Team — not yet on record
No current team members for Trinomab(Zhuhai) are on record yet. People surface from round filings, company disclosures, and coverage sessions.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Trinomab(Zhuhai) with a free account
·The complete investor list: 27 names
·Watch Trinomab(Zhuhai): the Monday email on marks, rounds and moves
